Taken together, results from the logistic model indicated that a combination of palmitoylethanolamide, theophylline, hypoxanthine, and CDH5 was the best signature of serum biomarkers for predicting advanced COPD. Here, CDH5 is linked to chronic obstructive pulmonary disease.